- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05907460
EXecution of Trans-Esophagus Echo Cardiogram in CardioPulmonary Resuscitation for Patients With Out-of-hospital Cardiac Arrest (EXECT_CPR)
September 30, 2024 updated by: Far Eastern Memorial Hospital
The purpose of this single center, randomized clinical control trial is to determine that changing chest compression site during cardiopulmonary resuscitation according to the examination of the TEE could increase the level of end-tidal CO2, which represents the quality of cardiopulmonary resuscitation, or not in adult patients with non-traumatic out-of-hospital cardiac arrest while comparing to those who don't receive examination of transesophageal echocardiography during cardiopulmonary resuscitation.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
132
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
New Taipei City
-
Banqiao, New Taipei City, Taiwan, 220
- Far Eastern Memorial Hospital
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
No
Description
Inclusion Criteria:
- Age ≥ 20 years-old
- Out-of-hospital cardiac arrest
- Non-trauma
Exclusion Criteria:
- Obvious signs of death appears, such as separation of head and body, rigor mortis, livor mortis, cankered corpse......etc.
- Family members clearly express the willing of do not attempt resuscitation or patients who have registered advance care planning not to attempt resuscitation.
- Patients not suitable for transesophageal ultrasound, such as patients with esophageal tumor, those whose probe cannot be placed......etc.
- Received Extracorporeal CPR.
- Achieving sustained ROSC before ED arrival
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
No Intervention: Control group
Perform standard advanced life support.
No examination of transesophageal echocardiography during cardiopulmonary resuscitation.
|
|
|
Experimental: Intervention group
Perform examination of transesophageal echocardiography during cardiopulmonary resuscitation and adjust the chest compression site to avoid left ventricular outflow tract according to the result of transesophageal echocardiography
|
Perform transesophageal echocardiography in patients with out-of-hospital cardiac arrest during cardiopulmonary resuscitation and adjust the chest compression site to compress the left ventricle and avoid left ventricular outflow tract.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Rate of sustained return of spontaneous circulation (ROSC)
Time Frame: 20 minutes after ROSC
|
successful restoration and maintenance of a patient's heartbeat and blood circulation after undergoing cardiopulmonary resuscitation (CPR) for at least 20 minutes
|
20 minutes after ROSC
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
end-tidal carbon dioxide (EtCO2)
Time Frame: During resuscitation
|
measuring end-tidal carbon dioxide during resuscitation
|
During resuscitation
|
|
Rate of any return of spontaneous circulation
Time Frame: 1 minutes after ROSC
|
successful restoration and maintenance of a patient's heartbeat and blood circulation after undergoing cardiopulmonary resuscitation (CPR)
|
1 minutes after ROSC
|
|
Rate of survival to discharge
Time Frame: 6 months after ROSC
|
successful restoration and maintenance of a patient's heartbeat and blood circulation and able to complete treatment course till discharge
|
6 months after ROSC
|
|
Rate of discharge with favorable neurological outcomes
Time Frame: 6 months after ROSC
|
using cerebral performance category score to measure neurologic outcomes of the patient at the time while patient's discharge.
CPC1 and 2 are consider as favorable neurological outcomes, CPC3 and 4 are consider as unfavorable neurological outcomes
|
6 months after ROSC
|
|
Rate of survival to ICU admission
Time Frame: 48 hours after ROSC
|
Successful restoration and stabilization of a patient's heartbeat and circulation, enabling safe transfer to the ICU.
|
48 hours after ROSC
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Study Chair: Jun-Tang Sun, MD, Msc, Attending physician of emergency medicine department
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
June 29, 2023
Primary Completion (Actual)
November 19, 2023
Study Completion (Actual)
November 19, 2023
Study Registration Dates
First Submitted
June 8, 2023
First Submitted That Met QC Criteria
June 8, 2023
First Posted (Actual)
June 18, 2023
Study Record Updates
Last Update Posted (Actual)
October 2, 2024
Last Update Submitted That Met QC Criteria
September 30, 2024
Last Verified
February 1, 2024
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 109070-F
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Out-Of-Hospital Cardiac Arrest
-
Singapore General HospitalDuke-NUS Graduate Medical SchoolRecruitingOut-Of-Hospital Cardiac ArrestSingapore
-
National Taiwan University HospitalRecruitingOut-Of-Hospital Cardiac ArrestTaiwan
-
King's College LondonKing's College Hospital NHS Trust; London Ambulance Service NHS TrustNot yet recruiting
-
Wroclaw Medical UniversityWroclaw Emergency Medical ServicesRecruiting
-
Emergency Medical Services, Capital Region, DenmarkTrygFonden, Denmark; Danish Heart Foundation; Zoll Medical CorporationRecruitingOut-Of-Hospital Cardiac ArrestDenmark
-
National Taiwan University HospitalActive, not recruiting
-
University Medical Centre MariborOHK Medical DevicesCompleted"The Effect of the Use of an Autotransfusion Device on Hemodynamic Parameters During Resuscitation".Cardiac Arrest | Out of Hospital Cardiac ArrestSlovenia
-
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen UniversityCompletedOut-Of-Hospital Cardiac Arrest
-
Centre Hospitalier Universitaire de BesançonHospices Civils de Lyon; University Hospital, Strasbourg, France; University... and other collaboratorsCompletedOut of Hospital Cardiac ArrestFrance
-
Medical University of ViennaLudwig Boltzmann Institute Digital Health and Patient Safety; Emergency Medical...CompletedCardiac Arrest, Out-Of-HospitalAustria
Clinical Trials on transesophageal echocardiography examination during cardiopulmonary resuscitation
-
University of AarhusRecruitingHeart Arrest | Cardiac Arrest (CA) | In-Hospital Cardiac ArrestDenmark, Norway
-
St. Jude Children's Research HospitalNational Cancer Institute (NCI)CompletedHodgkin LymphomaUnited States
-
Medical University of WarsawRecruiting
-
Advanced Circulatory SystemsNational Heart, Lung, and Blood Institute (NHLBI)TerminatedHeart Arrest | Cardiac Arrest | Cardiopulmonary Resuscitation | Death, Sudden, CardiacUnited States
-
Xiangya Hospital of Central South UniversityUnknownCoronary Heart DiseaseChina
-
National Medical Research Center for Children's...RecruitingAortic Valve InsufficiencyRussian Federation
-
Memorial Sloan Kettering Cancer CenterRecruitingBreast Cancer | CardiotoxicityUnited States